Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,081.29 -3.90 (-0.36%)

Streaming Delayed Price Updated: 12:55 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

99 100 Next >

Uncover the latest developments among S&P500 stocks in today's session. ↗

October 17, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.

Via Chartmill

Trump-Induced Volatility Aside, Novo Trades Cheap While Patents Protect Its Profits Until 2032 ↗

October 17, 2025

Novo Nordisk offers cheap stock with strong moat and long-term growth tailwinds. Trump's drug price cut suggestion caused short-term volatility but...

Via Benzinga

Topics Government Intellectual Property

Why Eli Lilly (LLY) Stock Is Down Today

October 17, 2025

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.5% in the afternoon session after political comments introduced significant uncertainty regarding the future pricing of the company’s...

Via StockStory

Topics Economy Government

Which S&P500 stocks are moving on Friday? ↗

October 17, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.

Via Chartmill

Eli Lilly Says Verzenio Reduced Risk of Death In Late-Stage Trial In Some Breast Cancer Patients ↗

October 17, 2025

Via Stocktwits

Eli Lilly Says Oral GLP-1 Drug Reduced Blood Sugar Levels In Two Late-Stage Trials ↗

October 15, 2025

Via Stocktwits

Trump Pledges To Cut Obesity Drug Prices. Novo Nordisk, Eli Lilly Stocks Dive. ↗

October 17, 2025

Novo Nordisk and Eli Lilly stocks slumped Friday after President Donald Trump said he would cut the price of obesity drugs.

Via Investor's Business Daily

Topics Government

Eli Lilly Shares Are Trading Lower Friday: What's Going On? ↗

October 17, 2025

Eli Lilly shares are trading lower Friday, among other GLP-1 drug manufacturers, following Trump's comments that fat-loss drugs will be a lot lower in price.

Via Benzinga

Topics Government

Which S&P500 stocks are gapping on Friday? ↗

October 17, 2025

Stay updated with the S&P500 gap up and gap down stocks on Friday. Get a glimpse of the market's movement during today's session.

Via Chartmill

Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Drugs? ↗

October 17, 2025

Trump's promise to cut cost of Novo Nordisk A/S drug Ozempic from $1,300 to $150 shakes GLP-1 gold rush, with potential impact on Eli Lilly and Pfizer.

Via Benzinga

Topics Government

Market Jitters: Dow Dips Amid Bank Fears While Eli Lilly and Novo Nordisk Tumble on Trump's Drug Pricing Comments

October 17, 2025

The financial markets experienced a turbulent Friday, October 17, 2025, as the Dow Jones Industrial Average faced a downturn driven by a resurgence of fears within the banking sector. Concurrently,...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Eli Lilly Sets Ambitious Sustainability Goals Despite Headwinds ↗

October 17, 2025

Eli Lilly's prescription for growth and sustainability includes a strong drug pipeline, revenue growth and energy investments.

Via Investor's Business Daily

Which S&P500 stocks are moving before the opening bell on Friday? ↗

October 17, 2025

Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session.

Via Chartmill

Eli Lilly Makes A Bold Claim For Its Biggest Cancer Drug ↗

October 17, 2025

Eli Lilly said Friday a combo using Verzenio cut the risk of death by nearly 16% over two years for breast cancer patients.

Via Investor's Business Daily

Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street? ↗

October 17, 2025

These stocks have climbed in the triple digits over the past few years.

Via The Motley Fool

Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program ↗

October 17, 2025

The FDA’s new National Priority Voucher pilot helps with faster drug reviews, cutting timelines from nearly a year to weeks.

Via Stocktwits

Eli Lilly, Novo Nordisk Stocks Fall After-Hours As Trump Pledges Swift Price Cuts For ‘Fat-Loss Drugs’ ↗

October 16, 2025

Novo Nordisk is also continuing discussions with the administration under the Most Favored Nation policy aimed at linking U.S. drug costs to global benchmarks.

Via Stocktwits

Topics Economy Government

Global Markets Brace for Impact as Investor Risk Aversion Escalates Amidst Geopolitical Tensions and Economic Headwinds

October 16, 2025

Global financial markets are currently navigating a treacherous landscape marked by a pronounced surge in investor risk aversion. As of October 16, 2025, a potent cocktail of persistent geopolitical...

Via MarketMinute

Topics Bonds Economy World Trade

Eli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out 'Fat-Loss Drugs' ↗

October 16, 2025

Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-loss drugs are going to go down in price.

Via Benzinga

Topics Government

Chesapeake Sells 9,900 Eli Lilly (LLY) Shares Worth $7.7 Million ↗

October 16, 2025

Via The Motley Fool

Topics Regulatory Compliance

2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades ↗

October 16, 2025

These companies are investing heavily into their pipelines and the payoff for long-term investors can be substantial.

Via The Motley Fool

Did Viking Therapeutics Just Say "Checkmate" to Eli Lilly? ↗

October 16, 2025

The smaller drugmaker is looking to disrupt a fast-growing market.

Via The Motley Fool

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. ↗

October 16, 2025

Investors should be able to count on these stocks to deliver steady and growing income over the long term.

Via The Motley Fool

Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead ↗

October 15, 2025

Novo Nordisk’s $4.7B Akero deal boosts its metabolic health pipeline, targeting Eli Lilly’s lead in obesity and liver disease treatments

Via MarketBeat

Topics World Trade

Chesapeake Asset Management Begins Investing in Ryder System. Is the Stock a Buy? ↗

October 15, 2025

Via The Motley Fool

Topics Economy Regulatory Compliance

Eli Lilly's Oral Weight Loss Drug Shows Superiority Over Two Approved Drugs ↗

October 15, 2025

Orforglipron meets key endpoints in Phase 3 trials, showing A1C reduction, weight loss, and cardiovascular benefits for type 2 diabetes.

Via Benzinga

Eli Lilly Stock: Elevated Momentum, Strong Analyst Backing, Near-Term Earnings Focus ↗

October 15, 2025

Eli Lilly's stock shows robust momentum and strong analyst support, driven by solid fundamentals and positive market sentiment, while upcoming earnings releases remain a focal point for investors.

Via Talk Markets

Meet the 1.4% Yield Dividend Stock That Could Soar in 2026 ↗

October 15, 2025

The company is one of two major players in the rapidly growing obesity drug market. Yet, the stock has lost half its value.

Via The Motley Fool

New to Investing? These Are 3 Solid Blue Chip Stocks You Can Build Your Portfolio Around ↗

October 15, 2025

Regardless of your investing knowledge or experience, you can't go wrong with these three behemoths in your portfolio.

Via The Motley Fool

Topics Artificial Intelligence

1 Reason Eli Lilly (LLY) Is One of the Best Healthcare Stocks You Can Buy Today ↗

October 14, 2025

Despite the company's run in recent years, it's not too late to buy.

Via The Motley Fool

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.